You can now get up to 20 free RNS alerts every day as a registered member. Clickhere to set-up your alerts.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed

Thu, 29th Dec 2022 09:26

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Strategic Minerals PLC, up 7.6% at 0.27 pence, 12-month range 0.20p - 0.45p. Says its subsidiary, Leigh Creek Copper Mine Pty Ltd, has lodged an application for a new Program for Environmental Protection & Rehabilitation with South Australia's Department of Energy & Mining. The lodgement of the PEPR is related to planned mining at Paltridge North, within Leigh Creek, and constitutes part of the expected 2023 re-opening of operations at Mountain of Light - also on the site - subject to funding.

----------

Tekcapital PLC, up 1.4% at 18.25 pence, 12-month range 15.65p - 37.80p. Investee Innovative Eyewear Inc licences outdoor brand Eddie Bauer for its smart eyewear through an agreement with Authentic Brands Group LLC. The company describes the contract as a "multi-year, global licensing agreement", without providing financial details. The Eddie Bauer smart eyewear collection is expected to launch in 2023.

----------

AIM - LOSERS

----------

Allergy Therapeutics PLC, down 52% at 5.45 pence, 12-month range 4.00p - 33.50p. Says its shares will be suspended next week, due to delays in completing the audit of its annual results. Back in September, the company announced its unaudited preliminary results for the financial year that ended June 30. It sunk to a pretax loss of GBP12.7 million from a profit of GBP3.7 million the year prior. Revenue dropped to GBP72.8 million from GBP84.3 million. "It is not aware of any material change that will be required to be made to the results, and it is actively working to finalise the audit and publication of its annual report and accounts," the commercial biotechnology firm says.

----------

Kazera Global PLC, down 15% at 0.90 pence, 12-month range 0.70p - 1.64p. Says its annual results will not be published before the end of the year, due to delays at its wholly-owned subsidiary African Tantalum (Proprietary) Ltd. The diamond and rare earths explorer now expects to release its results for the financial year that ended June 30 during February. As a result, its shares will be suspended from trading on AIM in London from Tuesday next week, the first trading day of 2023. Kazera expects a loss of GBP1.1 million on income of GBP107,000.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
7 Jan 2025 11:31

UK shareholder meetings calendar - next 7 days

13 Dec 2024 14:12

Kazera subsidiary WHM inks deal with Fujax South Africa

(Sharecast News) - Kazera Global announced on Friday that its subsidiary, Whale Head Minerals (WHM) has entered into a sales and offtake agreement wit...

13 Dec 2024 09:50

AIM WINNERS & LOSERS: Impax Asset Management sinks after SJP blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

20 Nov 2024 13:06

Kazera gets South Africa government okay for mineral sands project

(Alliance News) - Kazera Global PLC on Wednesday secured environmental authorisation for the Perdevlei concession in South Africa, leaving Kazera one ...

18 Sep 2024 12:36

UK shareholder meetings calendar - next 7 days

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.